Top Media Providers

Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings

Investing.comBy Investing.com

11/3/2026, 10:12:54 AM

EXECUTIVE SUMMARY

Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings....

Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings.

Published originally on Investing.com

Finance & Markets7m ago

Grey Secures CBN Approval to Operate as International Money Transfer Operator in Nigeria TechAfrica News

TechAfrica News

Finance & Markets12m ago

Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October Investing.com Australia

Investing.com Australia

Finance & Markets13m ago

US stock futures mixed as Apple slides, midterms loom....

Investing.com

Finance & Markets13m ago

Roundup settlement expected before Christmas, Bayer CEO says....

Investing.com

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!